MLYS
Mineralys Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website mineralystx.com
- Employees(FY) 12
- ISIN US6031701013
Performance
-2.59%
1W
-6.41%
1M
+10.98%
3M
-0.0%
6M
+52.79%
YTD
+87.18%
1Y
Profile
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Technical Analysis of MLYS 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-12 23:00
- 2024-11-12 10:12
Q3 2024 Mineralys Therapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-11 16:56
Mineralys Therapeutics Q3 Net Loss Widens(MT Newswires)
- 2024-11-11 16:05
- 2024-11-11 03:05
- 2024-11-05 16:05
- 2024-11-05 03:05
- 2024-11-04 16:05
- 2024-11-04 03:05
- 2024-10-30 08:00
- 2024-10-29 20:00
- 2024-10-22 08:00
- 2024-10-21 20:00
- 2024-10-20 09:10
- 2024-09-25 08:00
- 2024-09-24 20:00
- 2024-08-28 08:00
- 2024-08-27 20:00
- 2024-08-13 16:05
- 2024-08-13 04:05
- 2024-08-05 16:05
- 2024-08-05 04:05
- 2024-07-12 19:01
- 2024-07-12 19:01
- 2024-07-10 08:04
- 2024-06-21 03:11
- 2024-06-20 17:49
- 2024-06-15 02:53
- 2024-06-14 08:00
- 2024-06-14 02:43
Page 1 of 4
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.